Related content

EGF-R Small Inhibitors and Anti-EGF-R Antibodies: Advantages and Limits of a New Avenue in Anticancer Therapy

By  

Recent Patents on Anti-Cancer Drug Discovery, Vol. 1, Iss. 2, 2006-06 ,pp. : 209-222

Bentham Science Publishers

Access to resources Recommend Favorite

EGF, TGF-α, and EGF-R in Human Colorectal Adenocarcinoma

By Messa Caterina   Russo Francesco   Caruso Maria Gabriella   Di Leo Alfredo  

Acta Oncologica, Vol. 37, Iss. 3, 1998-07 ,pp. : 285-289

Informa Healthcare

Access to resources Recommend Favorite

Des mutations de KRAS aux mutations de RAS : vers une meilleure définition de la réponse aux anticorps anti-EGFR dans le cancer colorectal métastatique

By Lièvre A.  

Oncologie, Vol. 16, Iss. 2-3, 2014-02 ,pp. : 120-128

Springer Publishing Company

Access to resources Recommend Favorite

Toxicité et pharmacovigilance

By Py B.  

Oncologie, Vol. 8, Iss. 10, 2006-12 ,pp. : 887-887

Springer Publishing Company

Access to resources Recommend Favorite

Serum and Correspondent Tissue Measurements of Epidermal Growth Factor (EGF) and Epidermal Growth Factor Receptor (EGF-R): Clinical Relevance in Pancreatic Cancer and Chronic Pancreatitis

By  

International Journal of Gastrointestinal Cancer, Vol. 25, Iss. 2, 1999-04 ,pp. : 89-96

Humana Press, Inc

Access to resources Recommend Favorite